Sofosbuvir, Velpatasvir, and Voxilaprevir generic The sofosbuvir, velpatasvir and voxilaprevir combination is the first pan-genotypic fixed-dose combination drug prescribed to treat adult patients who suffer from genotype 1-6 chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). This fixed dose combination is used only when other treatments showed a poor response or have failed. More precisely, it is used in- • Patients who were earlier treated with a combination of drugs that included an NS5A inhibitor• Patients with genotype 1a or 3 infection and have previously been treated with a combination of drugs containing sofosbuvir but without an NS5A inhibitor This combination works by preventing the multiplication of the hepatitis C virus inside the body.
More Info about Sofosbuvir, Velpatasvir, and Voxilaprevir